Please try another search
For the nine months ended 30 September 2015, Trivascular Technologies Inc revenues increased 20% to $27.2M. Net loss increased 3% to $44.1M. Revenues reflect United States (U.S.) segment increase of 26% to $19M, International segment increase of 8% to $8.2M. Higher net loss reflects Sales, general and administrative increase of 8% to $39.5M (expense), Stock-based Compensation in Sales, gener increase of 100% to $2.6M (expense).
Period Ending: | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Total Revenue | 9.46 | 9.73 | 8.03 | 9.09 |
Gross Profit | 6 | 5.97 | 4.67 | 5.77 |
Operating Income | -11.42 | -12.81 | -13.55 | -12.53 |
Net Income | -13.58 | -14.86 | -15.64 | -14.49 |
Period Ending: | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Total Assets | 79.79 | 82.86 | 94.93 | 108.53 |
Total Liabilities | 78.27 | 70.19 | 69.6 | 68.96 |
Total Equity | 1.53 | 12.68 | 25.33 | 39.57 |
Period Ending: | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -39.04 | -26.82 | -12.65 | -53.58 |
Cash From Investing Activities | 30.67 | 15.12 | -0.13 | -46.4 |
Cash From Financing Activities | 10.4 | 0.77 | 0.06 | 94.86 |
Net Change in Cash | 2 | -10.93 | -12.78 | -5.21 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review